Get startedLog in
    Picture of SynAct Pharma AB logo

    SYNACT — SynAct Pharma AB News Story

    0.000.00%
    se flag iconLast trade - 00:00
    HealthcareHighly SpeculativeSmall CapSucker Stock
    All News

    Brief: Synact Pharma Announces Additional Data From Expand P2B Clinical Trial

    Picture of SynAct Pharma AB logoSynAct Pharma AB
    22/02/2024 06:35
    Feb 22 (Reuters) - SynAct Pharma AB  SYNACT.ST :
    * SYNACT PHARMA ANNOUNCES ADDITIONAL DATA FROM THE EXPAND
P2B
CLINICAL TRIAL SUPPORTING CONTINUED DEVELOPMENT OF THE COMPOUND
IN RHEUMATOID ARTHRITIS

Source text for Eikon:  ID:nMFN9FpTzv 
Further company coverage:  SYNACT.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

    Recent news on SynAct Pharma AB

    See all news